This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (7)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Hector R. Nava, MD; Marlys E. Schuh, MD; Raman Nambisan, MD; John L. Clark, MD; Harold O. Douglass, Jr, MD

Arch Surg. 1989;124(2):225-228.

Abstract
• The case reports of 40 patients with obstructive esophageal cancer treated with electrofulguration (EF) or neodymium (Nd)-YAG laser were reviewed. Surgery was contraindicated because of advanced carcinoma (17 patients), recurrence after resection (13 patients), recurrence after irradiation (four patients), and poor medical condition (four). Two patients refused surgery. There were 31 men and four women; mean age was 62 years. There were 31 adenocarcinomas, eight squamous cell carcinomas, and one metastatic breast carcinoma. Tumor locations were lower esophagus in 35 patients, middle esophagus in three, and cervical esophagus in two. Thirty-five patients had obstructions; two, bleeding, and three, both. None of the patients could swallow solids. A total of 255 treatments were given (mean, 6.6 per patient). The mean number of Nd-YAG treatments was 1.9; for EF, 1.3. All 40 patients tolerated solid food after treatment and the esophagus remained open from three to 14 weeks. Mean survival from first treatment was 11 months; from diagnosis, 17 months. Both techniques were safe and effective.

(Arch Surg 1989;149:225-228)

Author Affiliations
From the Department of Surgery, Roswell Park Memorial Institute, Buffalo.

Footnotes
Accepted for publication July 8, 1988.

Read before the Annual Meeting of the Society of Surgical Oncology, New Orleans, May 23, 1988.

Reprint requests to Roswell Park Memorial Institute, 666 Elm St, Buffalo, NY 14263 (Dr Nava).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?